Aerie Pharmaceuticals Inc (AERI) Financials

$15.25

$0.00 (0.00%)

As on 22-Nov-2022 09:30EDT

Market cap

$754 Mln

Revenue (TTM)

$214 Mln

P/E Ratio

--

P/B Ratio

34.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	213.94	194.13	83.14	69.89	24.18	--
Cost of Revenue	23.52	26.85	25.33	4.83	0.64	16.71
Gross Profit	190.42	167.29	57.81	65.06	23.54	-16.71
Operating Expenses	217.13	213.64	213.50	252.55	233.28	145.69
Operating Profit (EBIT)	-26.71	-46.35	-155.69	-187.49	-209.74	-145.69
Other Income	-8.52	-27.86	-22.17	-12.18	-22.82	-1.17
Profit before Tax	-35.23	-74.22	-177.86	-199.67	-232.57	-146.86
Provision for Tax	1.32	0.59	5.25	-0.09	0.00	-1.76
Profit after Tax (Net Income)	-36.56	-74.81	-183.10	-199.58	-232.57	-145.11
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-36.56	-74.81	-183.10	-199.58	-232.57	-145.11

Liabilities ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	-163.98	-17.33	23.97	166.95	227.81	135.60
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	406.24	323.73	273.61	202.01	6.45	129.49
Current Liabilities	133.33	124.99	104.47	83.65	50.78	25.18
Total Liabilities	508.92	431.39	402.05	452.61	285.04	290.28

Assets ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	72.78	75.74	70.29	76.27	64.87	36.13
Current Assets	302.81	355.65	331.76	376.34	220.18	254.14
Total Assets	508.92	431.39	402.05	452.61	285.04	290.28
Total Debt*	336.99	260.64	215.30	194.15	--	123.85
Net Current Assets	169.48	230.66	227.28	292.69	169.39	228.96

Cashflow ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	--	-99.15	-64.69	-150.43	-152.58	-93.21
Cash Flow from Investing Activities	--	-18.20	73.18	-183.25	20.79	-42.81
Cash from Financing Activities	--	2.97	-0.86	274.80	137.04	135.64
Net Cash Inflow / Outflow	--	-114.38	7.63	-58.88	5.25	-0.38

Financials Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	-0.72	-1.63	-3.98	-4.44	-5.54	-4.15
Cash EPS ($)	--	-0.81	-3.24	-4.03	-5.48	-4.11
Adjusted Book Value ($)	--	--	0.52	3.71	5.42	3.87
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-2.16	-1.41	-3.34	-3.63	-2.66
Free Cash Flow per Share ($)	--	-2.23	-1.47	-3.56	-4.38	-3.12

Profitability Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	--	-31.00	-61.00	-67.78	-95.46	-59.43
ROE (%)	--	-2,255.01	-191.81	-101.12	-127.99	-120.45
ROA (%)	-7.47	-17.95	-42.85	-54.11	-80.85	-53.89
EBIT Margin (%)	-10.86	-23.34	-182.08	-263.87	-951.30	--
Net Margin (%)	-17.80	-44.99	-300.30	-345.84	-17,138.47	12,402.14
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	105.41	1.34	0.19	1.89	--	--
EBIT Growth (%)	82.50	70.07	17.91	19.83	-57.89	-50.40
Net Profit Growth (%)	78.04	59.14	8.26	14.18	-60.28	-46.48
EPS Growth (%)	80.10	0.59	0.10	0.20	-0.34	-0.21
Book Value Growth (%)	-115.64	--	--	--	--	--

Valuation Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	--	-4.32	-3.39	-5.45	-6.52	-14.41
Price / Book Value	34.26	-18.63	25.93	6.51	6.66	15.42
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-350.17	-56.80	-5.09	-5.85	-5.77	-13.62
Close Price ($)	15.13	7.02	13.51	24.17	36.10	59.75
High Price ($)	15.37	21.30	26.26	50.10	74.75	66.60
Low Price ($)	4.81	6.95	9.01	17.15	32.18	37.30
Market Cap ($ Cr)	753.62	--	--	--	--	--

Solvency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	-1.91	-15.04	8.98	1.16	--	0.91
Short term debt to equity ratio	-0.03	-0.25	0.21	0.03	--	0.91
Current Ratio	2.27	2.85	3.18	4.50	4.34	10.09
Quick Ratio	1.92	2.52	2.92	4.25	4.14	10.09
Interest Coverage	-1.94	-1.57	-5.72	-12.09	-90.89	-61.53

Operating Efficiency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	34.53	81.81	67.38	54.88	11.23	--
Asset Turnover	0.44	0.47	0.19	0.19	0.08	--
Receivable days	--	202.11	207.31	107.32	41.01	--
Inventory Days	--	458.97	346.85	1,177.67	2,880.97	--
Payable days	--	116.40	155.69	951.21	5,312.93	129.56
Cash Conversion Cycle	--	544.68	398.47	333.78	-2,390.95	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.